{
  "report_id": "RPT_ID002_20260201_221749",
  "participant_id": "ID002",
  "generated_at": "2026-02-01T22:17:49.831506",
  "prediction": {
    "classification": "CONTROL",
    "probability": 0.18,
    "confidence": "HIGH",
    "target_condition": "neuropsychiatric"
  },
  "evaluation": {
    "verdict": "SATISFACTORY",
    "confidence_in_verdict": 0.86,
    "checklist_passed": 7,
    "checklist_total": 7
  },
  "key_findings": [
    {
      "domain": "GENOMICS",
      "finding": "Normal overall genomic deviation with two low polygenic risk scores for depression and anxiety; indicates lower genetic liability but does not eliminate environmental or other biological risk.",
      "direction": "NORMAL"
    },
    {
      "domain": "BRAIN_MRI",
      "finding": "Normal brain structure; preserved white matter; no focal or global atrophy; no structural brain disease detected.",
      "direction": "NORMAL"
    },
    {
      "domain": "BIOLOGICAL_ASSAY",
      "finding": "No abnormal biomarkers; inflammatory markers and HPA axis indicators within expected ranges; low contribution to risk.",
      "direction": "NORMAL"
    },
    {
      "domain": "MENTAL_HEALTH",
      "finding": "Minimal depressive/anxiety symptoms (PHQ-9 = 2, GAD-7 = 1); no psychiatric abnormalities detected; routine monitoring appropriate.",
      "direction": "NORMAL"
    },
    {
      "domain": "COGNITION",
      "finding": "Cognition intact with above-average executive function and normal memory; no cognitive-based risk signal.",
      "direction": "NORMAL"
    },
    {
      "domain": "DEMOGRAPHICS",
      "finding": "Demographic data available (Age 42, Male, 18 years education); provides non-modifiable context but shows no alarming risk signals.",
      "direction": "NORMAL"
    },
    {
      "domain": "LIFESTYLE",
      "finding": "Lifestyle data not supplied; limits assessment of sleep, activity, substance use, and stress as contributors to risk.",
      "direction": "NORMAL"
    }
  ],
  "reasoning": [
    "Step 1: Aggregated multimodal data show concordant normal-to-low risk across genomics, brain structure, biology, mental health, and cognition with no abnormalities.",
    "Step 2: Mental health screens indicate minimal symptoms (PHQ-9 2, GAD-7 1) and cognitive testing reveals preserved function, reducing likelihood of active neuropsychiatric disorder.",
    "Step 3: Neuroimaging (MRI) shows no structural brain disease; biological assays are within expected ranges; no inflammatory or endocrine signals of concern.",
    "Step 4: Two low polygenic risk scores for depression/anxiety further reduce genetic liability, reinforcing a protective risk profile rather than a predisposition to neuropsychiatric conditions.",
    "Step 5: Data gaps exist for lifestyle factors, which mildly limits risk-context integration but are unlikely to overturn the current low-risk signal given consistent cross-domain evidence.",
    "Step 6: Integrated interpretation: absence of self-reported symptoms, objective health indicators, and imaging/biomarker abnormalities supports a CONTROL classification for neuropsychiatric risk at this time."
  ],
  "clinical_summary": "Participant ID002 is a healthy 42-year-old male with normal neuroimaging, normal inflammatory and endocrine biomarkers, minimal depressive/anxiety symptoms, and preserved cognition. Genomics shows two low polygenic risk scores for mood disorders, suggesting lower genetic liability. Overall, the integrated multimodal profile indicates a LOW/ NORMAL neuropsychiatric risk with no current signal of elevated risk. Lifestyle data are unavailable, representing a data gap, but current evidence supports routine surveillance rather than immediate concern.",
  "execution": {
    "iterations": 1,
    "tokens_used": 58753,
    "domains_processed": [
      "GENOMICS",
      "BRAIN_MRI",
      "BIOLOGICAL_ASSAY",
      "MENTAL_HEALTH",
      "COGNITION",
      "DEMOGRAPHICS",
      "LIFESTYLE"
    ]
  },
  "decision_trace": [
    {
      "decision_id": "D001",
      "component": "Orchestrator",
      "decision_type": "PLAN_GENERATION",
      "input_summary": "Domains: GENOMICS, BRAIN_MRI, BIOLOGICAL_ASSAY, MENTAL_HEALTH, COGNITION, DEMOGRAPHICS, LIFESTYLE",
      "output_summary": "Generated 12-step plan",
      "reasoning": "This plan ensures complete data coverage, efficient token usage through domain-specific compression, and a coherent sequencing: anomaly detection -> feature prioritization -> domain compression -> cross-domain narrative -> hypothesis generation, all within the given token budget.",
      "timestamp": "2026-02-01T22:12:49.257628",
      "metadata": {}
    },
    {
      "decision_id": "D002",
      "component": "Predictor",
      "decision_type": "CLASSIFICATION",
      "input_summary": "Key findings: Normal overall genomic deviation with two low polygenic risk scores for depression and anxiety; indicates lower genetic liability but does not eliminate environmental or other biological risk., Normal brain structure; preserved white matter; no focal or global atrophy; no structural brain disease detected., No abnormal biomarkers; inflammatory markers and HPA axis indicators within expected ranges; low contribution to risk....",
      "output_summary": "CONTROL (p=0.180)",
      "reasoning": "Participant ID002 is a healthy 42-year-old male with normal neuroimaging, normal inflammatory and endocrine biomarkers, minimal depressive/anxiety symptoms, and preserved cognition. Genomics shows two low polygenic risk scores for mood disorders, suggesting lower genetic liability. Overall, the integrated multimodal profile indicates a LOW/ NORMAL neuropsychiatric risk with no current signal of elevated risk. Lifestyle data are unavailable, representing a data gap, but current evidence supports ",
      "timestamp": "2026-02-01T22:17:36.063401",
      "metadata": {
        "probability": 0.18,
        "classification": "CONTROL"
      }
    },
    {
      "decision_id": "D003",
      "component": "Critic",
      "decision_type": "EVALUATION",
      "input_summary": "Checklist: 7/7 passed",
      "output_summary": "SATISFACTORY",
      "reasoning": "The prediction is grounded in concordant, domain-aligned findings across genomics, brain MRI, biological assays, mental health screening, and cognition, all indicating very low neuropsychiatric risk. Critical domains for the target condition (brain and cognition) are processed, supporting clinical defensibility. Minor data gaps in lifestyle and explicit PRS interpretation slightly limit contextual risk assessment but do not overturn the current low-risk signal. Overall, the integrated multimodal",
      "timestamp": "2026-02-01T22:17:49.831427",
      "metadata": {}
    }
  ]
}